Cue Biopharma Inc organizacji Marża brutto

Jaka jest wartość Marża brutto organizacji Cue Biopharma Inc?

Wartość Marża brutto organizacji Cue Biopharma Inc to 100.00%

Jaka jest definicja Marża brutto?



Marża brutto to różnica między przychodem a kosztem sprzedaży towarów podzielona przez przychód i wyrażona w procentach.

Gross margin is a type of profit margin, specifically a form of profit divided by net revenue. It is generally calculated as the selling price of an item, minus the cost of goods sold (production or acquisition costs, not including indirect fixed costs like rent, or administrative costs). The purpose of margins is to give a description of the gross profit.

Marża brutto firm w Health Care sektor na NASDAQ w porównaniu do Cue Biopharma Inc

Czym się zajmuję organizacja Cue Biopharma Inc?

cue biopharma is an innovative immunotherapy company developing a novel, proprietary class of biologics engineered to selectively modulate the human immune system to treat a broad range of cancers and autoimmune disorders. we design biologics to engage and modulate the activity of disease-associated t cells in the patient’s body, offering significant therapeutic advantages while potentially minimizing or eliminating unwanted side effects. we believe our biologics allow us to target antigen-specific t cell populations in a variety of indications using a simple peptide exchange within previously-validated drug frameworks developed from the cue biologics platform. this flexibility could truncate the drug selection and development process, moving effective therapeutics from discovery to clinical validation more rapidly and cost efficiently than current industry standard timelines and costs. headquartered in kendall square, cambridge, ma, we are led by an experienced management team and sci

Firmy z marża brutto podobne do Cue Biopharma Inc